Related Experiment Video
Updated: Dec 20, 2025

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural
1Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Insights
Paediatric morphoea, a fibrosing skin disorder, presents challenges in management due to varied symptoms. This review details its diagnosis, activity markers, and treatment strategies for children.
Area of Science:
- Dermatology
- Rheumatology
- Paediatric Medicine
Background:
- Paediatric morphoea is a fibrosing condition affecting skin and subcutaneous tissues with unknown causes.
- Optimal management strategies are difficult to define due to diverse presentations and limited pediatric studies.
- This is the second part of a review, focusing on diagnosis, disease activity markers, management, and natural history.
Purpose of the Study:
- To provide a comprehensive overview of the diagnosis, disease activity markers, management, and natural history of paediatric morphoea.
- To synthesize current knowledge from relevant literature to aid clinicians in managing this condition.
- To address the ongoing challenge of defining optimum management strategies for paediatric morphoea.
Main Methods:
- A literature search was conducted on PubMed, MEDLINE, and Google Scholar.
- Keywords included 'pediatric morphea', 'juvenile localised scleroderma', and 'juvenile systemic sclerosis'.
- Relevant studies such as randomized trials, reviews, and original research articles were selected and analyzed.
Main Results:
- The review synthesizes information on diagnostic approaches for paediatric morphoea.
- Key markers for assessing disease activity are discussed.
- Current management strategies and the natural course of the condition in children are summarized.
Conclusions:
- Effective diagnosis and monitoring are crucial for managing paediatric morphoea.
- Evidence-based management strategies are essential for improving patient outcomes.
- Further research focusing on paediatric-specific studies is needed to optimize treatment protocols.
Abstract:
Paediatric morphoea is a debilitating fibrosing disorder of uncertain aetiology, affecting the skin and subcutaneous tissues. Defining optimum management strategies in paediatric morphoea remains an ongoing challenge, owing to the varied presentations and a relative paucity of paediatric-specific studies. We performed a literature search on PubMed, MEDLINE and Google Scholar, using keywords such as 'pediatric morphea', 'juvenile localised scleroderma' and 'juvenile systemic sclerosis'. Relevant studies, including randomized trials, reviews of standard current guidelines and original research articles, were selected and results analysed before summarizing them. In Part 1 of this review, we described the epidemiology, aetiopathogenesis and clinical classification; in this part, we discuss the diagnosis, markers of disease activity, management and natural history in paediatric morphoea.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation